In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole

Mycoses

Volumn 50, Issue 4, 2007, Pages 286-289

  Santos, D A ^a   Hamdan, J S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antifungal drugs; Dermatophytosis; In vitro resistance; Susceptibility

Indexed keywords

FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DILUTION; INCUBATION TEMPERATURE; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; STANDARD; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; MICROBIAL SENSITIVITY TESTS; QUALITY CONTROL; REFERENCE STANDARDS; TEMPERATURE; TIME; TRICHOPHYTON;

ARTHRODERMA BENHAMIAE; ARTHRODERMATACEAE; CANDIDA PARAPSILOSIS; FUNGI; ISSATCHENKIA ORIENTALIS; TRICHOPHYTON RUBRUM;

EID: 34250349162     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2007.01325.x     Document Type: Article

References (14)

1. Mukkerjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MA. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 2003 47 : 82 86.
2. Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995 8 : 240 59.
3. Perea S, Fothergill AW, Sutton DA, Rinaldi MG. Comparison of in vitro activities of variconazole and five established agents against different species of dermatophytes using a broth macrodilution method. J Clin Microbiol 2001 39 : 385 8.
4. Gupta AK, Kohli Y. In vitro susceptibility testing ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and non-dermatophytes, and in-vitro evaluation of combination antifungal activity. Br J Dermatol 2003 149 : 296 305.
5. Fernández-Torres B, Cabañes FJ, Carrillo-Muñoz A et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002 40 : 3999 4003.
6. Carrillo-Muñoz AJ, Fernández-Torres B, Cárdenes DC, Guarro J. In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility. Chemotherapy 2003 49 : 248 51.
7. National Committee for Clinical Laboratory Standards (NCCLS). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. Wayne, PA : National Committee for Clinical Laboratory Standards, 2002.
8. Barry AL, Pfaller MA, Brown SD et al. Quality control limits of broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol 2000 38 : 3457 9.
9. Butty P, Lebecq JC, Mallie M, Bastide JM. Evaluation of the susceptibility of dermatophytes to antifungal drugs: a new technique. J Med Vet Mycol 1995 33 : 403 9.
10. Norris HA, Eleski BE, Ghannoum MA. Optimal growth conditions for determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J Am Acad Dermatol 1999 40 : S9 S13.
11. Korting HC, Ollert M, Abeck D, GCDDSS GROUP. Results of German Multicenter Study of Antimicrobial Susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. Antimicrob Agents Chemother 1995 39 : 1206 8.
12. Jessup CJ, Warner RJ, Isham N, Hasan I, Ghannoum MA. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000 38 : 341 4.
13. Fernández-Torres B, Inza I, Guarro J. In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes. J Clin Microbiol 2003 41 : 5209 11.
14. Gupta AK, Einarson TR, Summerbell RC, Shear NH. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs 1998 55 : 645 74.